Eagle Bay Advisors’s Sanofi SNY Stock Holding History

Eagle Bay Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-256	Closed	-$14.8K	–	1036
2024 Q3	$14.8K	Hold	256	–	–	0.01%	695
2024 Q2	$12.4K	Hold	256	–	–	0.01%	518
2024 Q1	$12.4K	Hold	256	–	–	0.01%	533
2023 Q4	$12.7K	Hold	256	–	–	0.01%	482
2023 Q3	$13.7K	Hold	256	–	–	0.01%	565
2023 Q2	$13.8K	Hold	256	–	–	0.01%	564
2023 Q1	$13.9K	Sell	256 -95	-27%	-$4.62K	0.01%	562
2022 Q4	$17K	Sell	351 -136	-28%	-$5.97K	0.01%	549
2022 Q3	$17K	Sell	487 -77	-14%	-$3.43K	0.01%	536
2022 Q2	$28.2K	Buy	+564	New	+$29.9K	0.02%	493
2022 Q1	–	Sell	-509	Closed	-$26K	–	868
2021 Q4	$26K	Sell	509 -60	-11%	-$2.97K	0.02%	518
2021 Q3	$27K	Buy	569 +120	+27%	+$6.1K	0.02%	550
2021 Q2	$25K	Buy	+449	New	+$23.4K	0.02%	501

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Eagle Bay Advisors's SNY Position: Q4 2024 in Review

Eagle Bay Advisors sold out of Sanofi (SNY) in Q4 2024, closing a stake of 256 shares — an estimated $14.8K sold.

Eagle Bay Advisors first reported a position in SNY in Q2 2021 and held it in 13 quarters. The position peaked at $28.2K in Q2 2022. 732 funds tracked by Wall St. Rank hold SNY as of Q4 2024.

Eagle Bay Advisors reported no remaining Sanofi position as of Q4 2024 after selling out during the quarter.
Eagle Bay Advisors sold 256 Sanofi shares in Q4 2024, an estimated $14.8K.
Eagle Bay Advisors first reported a position in Sanofi in Q2 2021 and held it in 13 quarters.
Eagle Bay Advisors's Sanofi position peaked at $28.2K in Q2 2022.
732 funds tracked by Wall St. Rank held Sanofi as of Q4 2024.

Based on Eagle Bay Advisors's 13F filing for Q4 2024, filed 13 Jan 2025.